Mission Therapeutics

Mission Therapeutics is a private drug discovery and development company focused on selectively targeting deubiquitinating enzymes (DUBs) to address diseases with high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target DUBs—an emerging and so far difficult-to-drug class that is generating significant commercial interest.